Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Hypoglycemia has been considered as a major barrier to achieving the proper glycemic target in type 2 diabetes mellitus patients. In particular, severe hypoglycemia (SH), which is defined as a hypoglycemic episode requiring the assistance of another person to raise the patient's glucose level, is a serious complication of diabetes because of its possible fatal outcomes. Recently, the recommendations for diabetes care have emphasized a patient-centered approach, considering the individualized patient factors including hypoglycemia. Many studies have been performed which analyzed the risk factors and clinical outcomes for SH. From the studies, researchers recommend that targeting a less stringent glycosylated hemoglobin level and selecting a safer class of drugs for hypoglycemia are appropriate for patients with a high risk of SH. Also, careful clinical attention to prevent hypoglycemia, including intensive education, is necessary to minimize the risk of SH and SH-related fatal outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 2×
“99) VADT (2009) [5] Randomized controlled trial Total incidence of SH Follow-up duration: 5.”
BackgroundInzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
Epidemic obesity and type 2 diabetes in Asia
Yoon, K.-H., Lee, J.-H., Kim, J.-W., Cho, J. H., Choi, Y.-H., Ko, S.-H., Zimmet, P., & Son, H.-Y. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69703-1 · Cited by 1,580 · cited 1×
“Also, a linear correlation between BMI and β-cell mass has been reported in those with T2DM [37].”
BackgroundSelf-citationSevere hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389
Defining and Reporting Hypoglycemia in Diabetes
American Diabetes Association Workgroup on Hypoglycemia (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1245 · Cited by 1,146
Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus
Whitmer, R. A. (2009) · JAMA · doi:10.1001/jama.2009.460 · Cited by 1,128 · cited 1×
“64 in patients with three or more SH episodes) [54].”
BackgroundBonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933
Risk of hypoglycaemia in types 1 and 2 diabetes: Effects of treatment modalities and their duration
UK Hypoglycaemia Study Group (2007) · Diabetologia · doi:10.1007/s00125-007-0599-y · Cited by 825
Goto, A., Arah, O. A., Goto, M., Terauchi, Y., & Noda, M. (2013) · BMJ · doi:10.1136/bmj.f4533 · Cited by 492 · cited 2×
“Recent retrospective Japanese reports showed that SH was strongly associated with the risk of CVD (HR, 3.39; 95% CI, 1.25 to 9.18) and an additional updated metaanalysis from 10 studies also showed the same results (pooled relative risk [RR], 1.91; 95% CI, 1.69 to 2.15) [51].”
BackgroundInfluentialMechanisms of hypoglycemia-associated autonomic failure in diabetes
Cryer, P. E. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1215228 · Cited by 433 · cited 2×
“Sympathoadrenal activation generates the release of a large amount of catecholamines, and in combination with sympathetic neural activation, hemodynamic changes affect a marker influence on the cardiovascular system [14,42].”
BackgroundMiller, M. E., Bonds, D. E., Gerstein, H. C., Seaquist, E. R., Bergenstal, R. M., Calles-Escandon, J., Childress, R. D., Craven, T. E., Cuddihy, R. M., Dailey, G., et al. (2010) · BMJ · doi:10.1136/bmj.b5444 · Cited by 429
Chow, E., Bernjak, A., Williams, S., Fawdry, R. A., Hibbert, S., Freeman, J., Sheridan, P. J., & Heller, S. R. (2014) · Diabetes · doi:10.2337/db13-0468 · Cited by 403 · cited 1×
“The report that ectopic beats were particularly prominent during the night when the participants were asleep is evidence to suggest that we take care of these patients to avoid hypoglycemia at night in patients undergoing diabetes care [49].”
BackgroundSystematic review: glucose control and cardiovascular disease in type 2 diabetes
Kelly, T. N., Bazzano, L. A., Fonseca, V. A., Thethi, T. K., Reynolds, K., & He, J. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-6-200909150-00137 · Cited by 358 · cited 1×
“(2009) [11] Meta-analysis Total incidence of SH 5 Prospective RCT of 27,802 participants Standard treatment: 3.”
MethodHypoglycemia in patients with type 2 diabetes mellitus
Miller, C. D., Phillips, L. S., Ziemer, D. C., Gallina, D. L., Cook, C. B., & El-Kebbi, I. M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1653 · Cited by 341 · cited 3×
“(2001) [19] Cross sectional study Odds ratio for hypoglycemia (95% CI) 1,055 Participants Age (yr): 0.”
BackgroundPoor Cognitive Function and Risk of Severe Hypoglycemia in Type 2 Diabetes
Punthakee, Z., Miller, M. E., Launer, L. J., Williamson, J. D., Lazar, R. M., Cukierman-Yaffee, T., Seaquist, E. R., Ismail-Beigi, F., Sullivan, M. D., Lovato, L. C., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1855 · Cited by 337
Vascular disease and diabetes: Is hypoglycaemia an aggravating factor?
Wright, R. J., & Frier, B. M. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.865 · Cited by 336 · cited 2×
“SH also increases blood viscosity, and thrombogenic effects by releasing the catecholamines and other hormonal factors that can affect vascular compromise in the brain [45].”
BackgroundHypoglycaemia in insulin‐treated Type 2 diabetes: frequency, symptoms and impaired awareness
Henderson, J. N., Allen, K. V., Deary, I. J., & Frier, B. M. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01072.x · Cited by 287
Symptoms of hypoglycaemia in people with diabetes
McAulay, V., Deary, I. J., & Frier, B. M. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00620.x · Cited by 264 · cited 1×
“Sympathoadrenal activation generates the release of a large amount of catecholamines, and in combination with sympathetic neural activation, hemodynamic changes affect a marker influence on the cardiovascular system [14,42].”
BackgroundMechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia
Robinson, R. T. C. E., Harris, N. D., Ireland, R. H., Lee, S., Newman, C., & Heller, S. R. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1469 · Cited by 264
Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial
The ORIGIN Trial Investigators, Mellbin, L. G., Rydén, L., Riddle, M. C., Probstfield, J., Rosenstock, J., Díaz, R., Yusuf, S., & Gerstein, H. C. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht332 · Cited by 247 · cited 2×
“ORIGIN (2013) [40] Randomized controlled trial Hazard ratio (95% CI) for mortality”
BackgroundMethodfor the ADVANCE Collaborative group, de Galan, B. E., Zoungas, S., Chalmers, J., Anderson, C., Dufouil, C., Pillai, A., Cooper, M., Grobbee, D. E., Hackett, M., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1484-7 · Cited by 243
Intensive treatment and severe hypoglycemia among adults with type 2 diabetes
McCoy, R. G., Lipska, K. J., Yao, X., Ross, J. S., Montori, V. M., & Shah, N. D. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.2275 · Cited by 143 · cited 2×
“(2016) [13] Retrospective analysis Odds ratio for SH (95% CI) 31,542 Patients with type 2 diabetes who achieved and maintained a HbA1c level less than 7.”
BackgroundSignorovitch, J. E., Macaulay, D., Diener, M., Yan, Y., Wu, E. Q., Gruenberger, J. ‐., & Frier, B. M. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12031 · Cited by 125
Strachan, M. W., Deary, I. J., Ewing, F. M., & Frier, B. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.3.305 · Cited by 113 · cited 1×
“In addition, the anxiety and depression presented in patients with hypoglycemia has been noted previously [60].”
BackgroundPuente, E. C., Silverstein, J., Bree, A. J., Musikantow, D. R., Wozniak, D. F., Maloney, S., Daphna-Iken, D., & Fisher, S. J. (2010) · Diabetes · doi:10.2337/db09-1495 · Cited by 103 · cited 1×
“Animal studies found that SH led to necrosis of neurons in the hippocampus and cortical regions [56].”
BackgroundEffects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes
Koivikko, M. L., Karsikas, M., Salmela, P. I., Tapanainen, J. S., Ruokonen, A., Seppänen, T., Huikuri, H. V., & Perkiömäki, J. S. (2008) · Diabetologia · doi:10.1007/s00125-007-0902-y · Cited by 89 · cited 1×
“Hypoglycemia can affect cardiac repolarization, altered STsegment and T-wave morphology and prolongation of the QT interval, which can be proarrhythmogenic [46,47].”
BackgroundCox, D. J., Kovatchev, B., Kovatchev, B., Koev, D., Koeva, L., Dachev, S., Tcharaktchiev, D., Protopopova, A., Gonder-Frederick, L., & Clarke, W. (2004) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm1104_4 · Cited by 88 · cited 1×
“To prevent hypoglycemia, intact cognitive function to regulate activity levels and dietary pattern, recognizing symptoms and responsiveness related with glycemic levels, predicting situations in which hypoglycemia may occur, and initiating appropriate mitigating actions are essential [32].”
BackgroundGoto, A., Goto, M., Terauchi, Y., Yamaguchi, N., & Noda, M. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002875 · Cited by 67 · cited 2×
“(2016) [51] Meta-analysis Pooled RR for cardiovascular disease (95% CI)”
BackgroundMethodHypoglycemia preceding fatal car collisions
Cox, D. J., Kovatchev, B., Vandecar, K., Gonder-Frederick, L., Ritterband, L., & Clarke, W. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1836 · Cited by 48
Davis, M., Mellman, M., Friedman, S., Chang, C. J., & Shamoon, H. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90349-2 · Cited by 33
Cited by
Severe hypoglycemia risk with long-acting insulin analogs vs neutral protamine Hagedorn insulin
Bradley, M. C., Chillarige, Y., Lee, H., Wu, X., Parulekar, S., Muthuri, S., Wernecke, M., MaCurdy, T. E., Kelman, J. A., & Graham, D. J. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.9176 · Cited by 45
Cheng, A. Y. Y., Wong, J., Freemantle, N., Acharya, S. H., & Ekinci, E. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00925-8 · Cited by 20
Lee, S., Ock, M., Kim, H., & Kim, H. (2020) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2450 · Cited by 13
“Information regarding the presence of cerebrovascular disease, ischemic heart disease, and heart failure was extracted.(29) Other comorbidities that could affect hypoglycemia, such as dementia, chronic kidney disease, cancer, alcohol-related disorders, hypertension, dyslipidemia, and chronic liver disease, were analyz…”
Background
Metadata
- Authors
- Yun, J.-S., & Ko, S.-H.
- Venue
- Diabetes & Metabolism Journal
- Publisher
- Korean Diabetes Association
- Published
- 2016
- Volume
- 40
- Issue
- 6
- Pages
- 423
- ISSN
- 2233-6079 (ISSN-L)
- 2233-6087
- OpenAlex
- W2531918455
- Cited by
- 75
- References
- 31
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.